STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 81 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $717,000 | -7.0% | 64,600 | -22.9% | 0.06% | -11.1% |
| Q2 2017 | $771,000 | -35.0% | 83,785 | -39.6% | 0.06% | -35.7% |
| Q1 2017 | $1,187,000 | -10.3% | 138,785 | +12.1% | 0.10% | -20.3% |
| Q4 2016 | $1,324,000 | +28.9% | 123,785 | +30.6% | 0.12% | +29.5% |
| Q3 2016 | $1,027,000 | +60.0% | 94,785 | 0.0% | 0.10% | +25.0% |
| Q2 2016 | $642,000 | +45.2% | 94,785 | 0.0% | 0.08% | +22.6% |
| Q1 2016 | $442,000 | -22.7% | 94,785 | +46.3% | 0.06% | -30.3% |
| Q3 2015 | $572,000 | -2.9% | 64,785 | +29.6% | 0.09% | -2.2% |
| Q2 2015 | $589,000 | -18.6% | 50,000 | 0.0% | 0.09% | -9.0% |
| Q1 2015 | $724,000 | – | 50,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |